|
|
|
Volumn 8, Issue 44, 1999, Pages 165-167
|
|
Raloxifene
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ESTROGEN;
RALOXIFENE;
TAMOXIFEN;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
BONE MINERAL;
BREAST CANCER;
CANCER RISK;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
DEEP VEIN THROMBOSIS;
FEMALE;
FLATULENCE;
HORMONE SUBSTITUTION;
HOT FLUSH;
HUMAN;
LUNG EMBOLISM;
MASTALGIA;
MENOPAUSE;
MENORRHAGIA;
METHODOLOGY;
MUSCLE CRAMP;
NONHUMAN;
OSTEOPOROSIS;
OVARY CANCER;
POSTMENOPAUSE;
PRIMARY PREVENTION;
SECONDARY PREVENTION;
SHORT SURVEY;
SLEEP DISORDER;
SWEAT;
URINE INCONTINENCE;
VERTEBRA FRACTURE;
ARTICLE;
BREAST TUMOR;
CHEMICALLY INDUCED DISORDER;
COMPARATIVE STUDY;
FRACTURE;
POSTMENOPAUSE OSTEOPOROSIS;
TREATMENT OUTCOME;
UTERUS CANCER;
BREAST NEOPLASMS;
CLINICAL TRIALS;
ESTROGENS;
FEMALE;
FRACTURES, BONE;
HUMANS;
OSTEOPOROSIS, POSTMENOPAUSAL;
RALOXIFENE;
SELECTIVE ESTROGEN RECEPTOR MODULATORS;
TREATMENT OUTCOME;
UTERINE NEOPLASMS;
|
|
EID: 0032757589
PISSN: 11677422
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (9)
|
|
References (10)
|